The Repeated Assay That Turned Two Positives into Twenty
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
The Repeated Assay That Turned Two Positives into Twenty
-
Narrated by:
-
Written by:
The Repeated Assay That Turned Two Positives into Twenty
In this episode, we present the sequence of events behind a controversial 2009 Science paper and the lab work, people, and decisions that propelled it into the spotlight. What choices and pressures turned two initial positives into a dataset of twenty, and how did that shape patients’ hopes?
Person: Judy Mikovits
Location: Reno
Date: 2009-10-08
Topic: XMRV and ME/CFS
Institution: Whittemore Peterson Institute
- A graduate student ran twenty patient samples through a standard assay late at night in 2008 and initially found two positives.
- Instead of stopping, lab conditions were adjusted repeatedly until all twenty samples matched the positive result.
- Judy Mikovits returned to research as research director at the privately funded Whittemore Peterson Institute after years outside federal labs.
- Collaboration began in 2007 between Mikovits and Robert Silverman, who had co-discovered XMRV in prostate cancer tissue.
- The October 8, 2009 Science paper reported XMRV in 67% of ME/CFS patients and became a focal point for patients and the scientific community.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
adbl_web_anon_alc_button_suppression_t1
No reviews yet